Korean Vivax Malaria

III. Curative Effect and Toxicity of Primaquine in Doses from 10 to 30 mg. Daily

Ralph Jones Jr.
Search for other papers by Ralph Jones Jr. in
Current site
Google Scholar
PubMed
Close
,
Lawrence S. Jackson
Search for other papers by Lawrence S. Jackson in
Current site
Google Scholar
PubMed
Close
,
Anthony Di Lorenzo
Search for other papers by Anthony Di Lorenzo in
Current site
Google Scholar
PubMed
Close
,
Ralph L. Marx
Search for other papers by Ralph L. Marx in
Current site
Google Scholar
PubMed
Close
,
Bertram L. Levy
Search for other papers by Bertram L. Levy in
Current site
Google Scholar
PubMed
Close
,
Edward C. Kenny
Search for other papers by Edward C. Kenny in
Current site
Google Scholar
PubMed
Close
,
Marvin Gilbert
Search for other papers by Marvin Gilbert in
Current site
Google Scholar
PubMed
Close
,
Marian N. Johnston
Search for other papers by Marian N. Johnston in
Current site
Google Scholar
PubMed
Close
, and
Alf S. Alving
Search for other papers by Alf S. Alving in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

A study of the therapeutic effectiveness and toxicity of primaquine in daily doses of 10, 15, 20, and 30 mg. (base) daily for 7 or 14 days, administered concurrently with 1.5 gm. (base) of chloroquine in 3 days, at the time of an acute attack of vivax malaria of Korean origin is reported. The relapse rate in patients treated with chloroquine alone was 43.8 per cent. The relapse rate was reduced to less than 3 per cent by all regimens of primaquine used. These results indicate that a daily dose of 10 mg. of primaquine administered for 14 consecutive days is adequate for the curative treatment of vivax malaria of Korean origin. A daily dose of 20 mg. administered for 7 days was effective in reducing the relapse rate.

No significant toxicity was observed with doses of 10 and 15 mg. daily. A daily dose of 20 mg. of primaquine produced acute severe intravascular hemolysis in one of 14 Negroes. This dose was well tolerated by all other patients. Mild abdominal pain and cyanosis due to methemoglobinemia occurred in approximately one-fourth of the white patients treated with 30 mg. of primaquine daily, but these effects were not severe enough to interfere with normal activity.

Author Notes

Department of Medicine, University of Pennsylvania.

Major, Captain, Colonel, Major, respectively, MC, U.S.A.

Captain, MC, U.S.N.

Lieut., MC, U.S.N.R.

Department of Medicine, Children's Hospital, Philadelphia, Pa.

Department of Medicine, University of Chicago.

Save